Kazuto Kato: the ethics of editing humanity
By Gary Humphreys,
Bulletin of the World Health Organization
| 09. 01. 2021
Photo from Kazuto Kato’s biography at
University of Oxford’s Faculty of Law
Gary Humphreys talks to Kazuto Kato about the ethical and societal challenges posed by biotechnologies that allow for the editing of the human genome.
Q: You started out working in developmental biology. How did you become interested in the field of ethics and governance of biomedicine?
A: As a student, I always had a broad interest in the societal issues related to biological science and its application and was actually a member of a student club that focused on such issues. I was also encouraged to look at issues outside the laboratory by my uncle, Professor Shuzo Nishimura, a pioneer in the field of health economics in Japan. Of course, I also had nine years at Kyoto University and four years at the University of Cambridge with Sir John Gurdon studying biology, with a focus on stem cell biology and genomics. This background has helped me navigate what is sometimes complex terrain.
Q: Given that complexity, can you start by giving our readers a simple definition of genomics...
Related Articles
Riquet Mammoth Kakao (c.1920)
by Ludwig Hohlwein, Public Domain via Flickr
Colossal, the de-extinction company, scored headlines (1, 2, 3, 4, 5) recently by announcing that they had created mice! Not just any mice, not even colossal mice, but genetically engineered, normal-size “woolly mice” that are the result of editing seven genes in mouse embryos. This Colossal presented as an important step toward making a specimen of charismatic megafauna – a...
By Ben Johnson, Nature | 02.14.2025
A London-based biotech has amassed the world’s largest ethically sourced foundational biodiversity database for training artificial intelligence (AI) by setting up partnerships with 25 countries around the world. The startup, Basecamp Research, announced in January the launch of a new...
By Isaac Schultz, Gizmodo | 10.18.2024
Colossal Biosciences, a company mainly known for intending to genetically engineer proxies for several iconic extinct species, announced this week that it has made major steps towards the de-extinction of the thylacine, or Tasmanian tiger.
The thylacine was a carnivorous...
By Russ Burlingame, Comicbook | 07.23.2024
Colossal Laboratories and Biosciences, a biotech company that's putting together plans to orchestrate the de-extinction for animals like the dodo and the wooly mammoth, made some waves on Reddit recently when they petitioned the United Federation of Planets -- the...